Compare Lupin Ltd with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DIVIS LABORATORIES - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DIVIS LABORATORIES LUPIN/
DIVIS LABORATORIES
 
P/E (TTM) x 46.9 33.8 138.6% View Chart
P/BV x 2.4 6.5 37.0% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 LUPIN   DIVIS LABORATORIES
EQUITY SHARE DATA
    LUPIN
Mar-19
DIVIS LABORATORIES
Mar-19
LUPIN/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9861,639 60.1%   
Low Rs7201,115 64.6%   
Sales per share (Unadj.) Rs369.5186.3 198.3%  
Earnings per share (Unadj.) Rs13.451.0 26.3%  
Cash flow per share (Unadj.) Rs37.457.3 65.2%  
Dividends per share (Unadj.) Rs016.00 0.0%  
Dividend yield (eoy) %01.2 0.0%  
Book value per share (Unadj.) Rs303.7261.8 116.0%  
Shares outstanding (eoy) m452.49265.47 170.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.37.4 31.2%   
Avg P/E ratio x63.627.0 235.5%  
P/CF ratio (eoy) x22.824.0 95.0%  
Price / Book Value ratio x2.85.3 53.4%  
Dividend payout %031.4 0.0%   
Avg Mkt Cap Rs m386,064365,592 105.6%   
No. of employees `00017.711.8 149.3%   
Total wages/salary Rs m31,5135,423 581.1%   
Avg. sales/employee Rs Th9,453.84,175.1 226.4%   
Avg. wages/employee Rs Th1,782.0457.7 389.3%   
Avg. net profit/employee Rs Th343.01,141.8 30.0%   
INCOME DATA
Net Sales Rs m167,18249,463 338.0%  
Other income Rs m3,6401,556 233.9%   
Total revenues Rs m170,82251,019 334.8%   
Gross profit Rs m28,82218,718 154.0%  
Depreciation Rs m10,8501,689 642.4%   
Interest Rs m3,07835 8,795.1%   
Profit before tax Rs m18,53418,551 99.9%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,0175,023 179.5%   
Profit after tax Rs m6,06613,527 44.8%  
Gross profit margin %17.237.8 45.6%  
Effective tax rate %48.727.1 179.7%   
Net profit margin %3.627.3 13.3%  
BALANCE SHEET DATA
Current assets Rs m138,53646,501 297.9%   
Current liabilities Rs m61,2998,468 723.9%   
Net working cap to sales %46.276.9 60.1%  
Current ratio x2.35.5 41.2%  
Inventory Days Days84131 64.0%  
Debtors Days Days11286 131.0%  
Net fixed assets Rs m127,51625,797 494.3%   
Share capital Rs m905531 170.5%   
"Free" reserves Rs m136,51768,962 198.0%   
Net worth Rs m137,42269,493 197.7%   
Long term debt Rs m66,4170-   
Total assets Rs m279,49480,383 347.7%  
Interest coverage x7.0531.0 1.3%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.60.6 97.2%   
Return on assets %3.316.9 19.4%  
Return on equity %4.419.5 22.7%  
Return on capital %8.926.7 33.3%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m59,41441,238 144.1%   
Fx outflow Rs m22,28212,405 179.6%   
Net fx Rs m37,13228,833 128.8%   
CASH FLOW
From Operations Rs m16,6609,543 174.6%  
From Investments Rs m-32,825-6,854 478.9%  
From Financial Activity Rs m7,441-2,459 -302.6%  
Net Cashflow Rs m-8,724230 -3,799.5%  

Share Holding

Indian Promoters % 46.6 52.0 89.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 11.8 95.8%  
FIIs % 31.9 19.0 167.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.2 58.7%  
Shareholders   98,259 31,796 309.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   WOCKHARDT  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON   FULFORD INDIA  

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Oct 16, 2019 12:49 PM

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS